Reproductive Drugs Flashcards
(16 cards)
MOA: Inhibit secretion of LH and FSH.
Side Effects: high risk for endometrial cancer.
Ethinyl estradiol (estrogen)
MOA: Inhibit secretion of LH and FSH.
MOA: Act at androgen receptors–> masculinization effects.
Levonorgestrel (synthetic progestin)
Clinical use: Extended preparation: 91 days on, 7 days off.
Side Effect: Increased risk for breakthrough bleeding.
Seasonal/Seasonique
Clinical Use: Continuous prep: 365 days on–> no periods
Side Effect: Increased risk for breakthrough bleeding.
Lybrel
Used because it has lower occurrence of acne, PMS, weight gain, and hirsutism.
MOA: Agonist at progesterone receptors.
MOA: Blocks mineralocorticoid and androgen receptors.
Side Effect: increase risk for venous thromboembolism.
Drospirenone (progestin)
Luteolytic drug. Given with prostaglandins to terminate pregnancy.
MOA: Antagonist at progesterone and glucocorticoid receptors.
Mifepristone (RU-486 abortion drug)
High dose levonorgestrel
Plan B
Selective estrogen receptor modulator–> Stimulates gonadotropin (FSH and LH) relate by blocking negative feedback.
Clomiphene (fertility drug)
Analog of GnRH–> Stimulates gonadotropin release
Gonadorelin (fertility drug)
Analogs of LH and/or FSH:
Gonadotropins (hCG) (Fertility drug)
Primary tx for vasomotor symptoms.
Conjugated estrogen, purified from urine of pregnant horses.
Increased risk for venous thrombosis and stroke.
Increase risk for endometrial cancer in non hysterectomized women:
Premarin (HRT)
Primary tx for vasomotor symptoms.
Estrogen + Progestin
Increase risk of CHD, venous thrombosis, breast cancer.
Reduced osteoporosis, hot flashes and incidence of colorectal cancer.
Prempro (HRT)
Alpha-1 selective antagonist
1st line tx for BPH.
Relieves LUTS.
Tamsulosin
Nonselective alpha antagonist.
1st line tx for BPH.
Relaxes vascular smooth muscle, but everywhere!
Side effect: Hypotension
Doxazosin
5- alpha reductase inhibitor (prevents conversion of testosterone to active DHT).
BPH: decreases size of prostate but doesn’t alleviate LUTS.
Dutasteride
PDE-5 Inhibitors
Prevents conversion of cGMP to inactive form
Treat ED.
SildenaFIL
VardeaFIL
TadalaFIL